Stifel Financial Corp Dr Reddys Laboratories LTD Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Stifel Financial Corp holds 4,786 shares of RDY stock, worth $69,301. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,786

Previous 5,132 6.74%

Holding current value

$69,301

Previous $391,000 2.81%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$75.41 - $84.21 $26,091 - $29,136	-346 Reduced 6.74%	4,786 $380,000
Q2 2024 Aug 13, 2024	SELL	$68.26 - $76.19 $11,126 - $12,418	-163 Reduced 3.08%	5,132 $391,000
Q1 2024 May 13, 2024	BUY	$67.36 - $77.59 $538 - $620	8 Added 0.15%	5,295 $388,000
Q4 2023 Feb 12, 2024	SELL	$64.27 - $69.9 $2,377 - $2,586	-37 Reduced 0.69%	5,287 $367,000
Q3 2023 Nov 13, 2023	BUY	$61.9 - $72.77 $1,485 - $1,746	24 Added 0.45%	5,324 $356,000
Q2 2023 Aug 14, 2023	SELL	$53.34 - $63.11 $11,841 - $14,010	-222 Reduced 4.02%	5,300 $334,000
Q1 2023 May 12, 2023	BUY	$51.63 - $56.93 $19,257 - $21,234	373 Added 7.24%	5,522 $314,000
Q4 2022 Feb 13, 2023	SELL	$51.15 - $57.45 $10,025 - $11,260	-196 Reduced 3.67%	5,149 $266,000
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $2,395 - $2,751	-48 Reduced 0.89%	5,345 $280,000
Q2 2022 Aug 15, 2022	BUY	$49.62 - $58.13 $14,786 - $17,322	298 Added 5.85%	5,393 $299,000
Q1 2022 May 13, 2022	BUY	$48.27 - $65.25 $1,303 - $1,761	27 Added 0.53%	5,095 $284,000
Q4 2021 Feb 14, 2022	SELL	$59.5 - $67.25 $6,664 - $7,532	-112 Reduced 2.16%	5,068 $332,000
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $24,015 - $30,040	-399 Reduced 7.15%	5,180 $337,000
Q2 2021 Aug 13, 2021	BUY	$62.12 - $74.2 $36,588 - $43,703	589 Added 11.8%	5,579 $410,000
Q1 2021 May 14, 2021	SELL	$57.98 - $73.08 $1.15 Million - $1.45 Million	-19,864 Reduced 79.92%	4,990 $306,000
Q4 2020 Feb 12, 2021	BUY	$62.61 - $71.29 $50,088 - $57,032	800 Added 3.33%	24,854 $1.77 Million
Q3 2020 Nov 16, 2020	SELL	$51.39 - $72.41 $10,586 - $14,916	-206 Reduced 0.85%	24,054 $1.67 Million
Q2 2020 Aug 14, 2020	BUY	$39.55 - $54.65 $67,353 - $93,068	1,703 Added 7.55%	24,260 $1.29 Million
Q1 2020 May 14, 2020	SELL	$34.75 - $45.85 $80,237 - $105,867	-2,309 Reduced 9.29%	22,557 $924,000
Q4 2019 Feb 13, 2020	SELL	$36.66 - $41.78 $16,167 - $18,424	-441 Reduced 1.74%	24,866 $1.03 Million
Q3 2019 Nov 19, 2019	SELL	$34.82 - $39.26 $6,128 - $6,909	-176 Reduced 0.69%	25,307 $969,000
Q3 2019 Nov 13, 2019	SELL	$34.82 - $39.26 $1,218 - $1,374	-35 Reduced 0.14%	25,483 $976,000
Q2 2019 Aug 14, 2019	BUY	$36.05 - $42.76 $919,923 - $1.09 Million	25,518 New	25,518 $964,000

Others Institutions Holding RDY

# of Institutions

245

Shares Held

23.1M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.4B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Dr Reddys Laboratories LTD Transaction History